Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Sant Joan Despi

7 clinical trials in Sant Joan Despi, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Sant Joan Despi at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Sant Joan Despi

Open in trial search

Study of chemotherapy drug combination with or without heated chemotherapy in the abdomen for patients with advanced colon cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fundacion Para La Investigacion Biomedica De Cordoba

Study on Donepezil for Mild Cognitive Impairment in Parkinson's Disease Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Donepezil Hydrochloride
  • Sponsor:Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Rheumatoid arthritis

Not recruiting

Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Eli Lilly & Co.

Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Asociacion Grupo Tratamiento De Tumores Digestivos

Multiple sclerosis

Not recruiting

Study on the Safety and Effectiveness of TolDec and Immunotherapy for Patients with Relapsing-Remitting Multiple Sclerosis

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Autologous tolerogenic dendritic cells
  • Sponsor:Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer

Plasma cell myeloma

Not recruiting

Study of Belantamab Mafodotin, Carfilzomib, and Dexamethasone for Patients with Relapsed Multiple Myeloma Resistant to Lenalidomide

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belantamab Mafodotin
  • Sponsor:Fundacion PETHEMA

Other cities in Spain

The busiest research cities in the country

All 214 cities in Spain

Clinical research in Sant Joan Despi

What the registry says about research in the country

01 Neurological Disorders

Innovative research focusing on multiple sclerosis through dendritic cell therapy combined with immunotherapy, exploring new treatment approaches for patients with relapsing-remitting forms of the disease.

  • Multiple Sclerosis Treatment
  • Immunotherapy Research
  • Cell-based Therapies

Studies aim to evaluate both radiological efficacy and safety profiles of combined therapeutic approaches.

02 Movement Disorders

Clinical investigations examining cognitive improvements in patients with Parkinson's disease, specifically targeting mild cognitive impairment through medication-based interventions.

  • Cognitive Performance
  • Long-term Treatment Effects
  • Neurodegenerative Disease Management

Research focuses on evaluating treatment effectiveness over extended periods.

03 Otology Research

Advanced studies on Ménière's disease treatment, comparing different drug delivery methods to address symptoms including vertigo, tinnitus, and hearing loss.

  • Vestibular Disorders
  • Drug Delivery Systems
  • Symptom Management

Investigations center on improving treatment administration and patient outcomes.

04 Hematologic Oncology

Groundbreaking research in multiple myeloma treatment, investigating combination therapies for patients with relapsed disease who show resistance to conventional treatments.

  • Cancer Therapeutics
  • Drug Combinations
  • Treatment Resistance

Studies focus on determining optimal dosing and evaluating treatment effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.